With 165,000 Patients Already, CBDT Is Positioned To Become A Medical Cannabis & CBD Retail Killer ... But It Doesn't End There
AGORACOM Small Cap CEO Interviews - Podcast tekijän mukaan AGORACOM
Kategoriat:
At 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for. Add in the fact it is now on a ~ $USD 4,000,000 annualized revenue run rate for 2019 and it becomes the kind of company small cap investors have been dying to find.
But it doesn't end there.
The Company is set to expand rapidly by taking its proven model into the franchise world for rapid expansion across the USA, with 4 applications already received in the last 30 days, as well as, launch its CBD extraction facility with an initial capacity of 6,000 Kg per year.
But it doesn't end there.
The Company's new CEO, Steven McAuley, who replaced the previous management team in January, is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We've never seen a Six Sigma certified CEO in the Canadian small cap markets. Never.
Grab your favourite cold beverage here in hot August and settle in for what may be your next great small cap investment.
